© 2014 Landes Bioscience. PTK6/Brk is a non-receptor tyrosine kinase overexpressed in cancer. Here we demonstrate that cytosolic PTK6 is rapidly and robustly induced in response to hypoxic conditions in a HIF-1-independent manner. Furthermore, a proportion of hypoxic PTK6 subsequently re-localized to the cell membrane. We observed that the rapid stabilization of PTK6 is associated with a decrease in PTK6 ubiquitylation and we have identified c-Cbl as a putative PTK6 E3 ligase in normoxia. The consequences of hypoxia-induced PTK6 stabilization and subcellular re-localization to the plasma membrane include increased cell motility and invasion, suggesting PTK6 targeting as a therapeutic approach to reduce hypoxia-regulated metastatic potential...
PTK6, also known as Brk, is highly expressed in over 80% of breast cancers. In the last decade sever...
Background: Proteins that are required for anchorage-independent survival of tumor cells represent a...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and is c...
© 2014 Landes Bioscience. PTK6/Brk is a non-receptor tyrosine kinase overexpressed in cancer. Here w...
This article has been made available through the Brunel Open Access Publishing Fund.PTK6/Brk is a no...
Item does not contain fulltextPTK6/Brk is a non-receptor tyrosine kinase overexpressed in cancer. He...
Basal-type triple-negative breast cancers (TNBC) are aggressive and difficult to treat relative to l...
<div><p>Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emer...
The non-receptor tyrosine kinase, PTK6/BRK, is highly expressed in multiple tumor types, including p...
Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emerging as ...
Deregulated signaling via receptor tyrosine kinase (RTK) pathways is prevalent in numerous types of ...
Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated wi...
Breast cancer is unanimously considered a highly heterogeneous disease due to its diverse molecular ...
Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated wi...
PTK6 (also known as Brk) is an intracellular tyrosine kinase whose expression is up-regulated in sev...
PTK6, also known as Brk, is highly expressed in over 80% of breast cancers. In the last decade sever...
Background: Proteins that are required for anchorage-independent survival of tumor cells represent a...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and is c...
© 2014 Landes Bioscience. PTK6/Brk is a non-receptor tyrosine kinase overexpressed in cancer. Here w...
This article has been made available through the Brunel Open Access Publishing Fund.PTK6/Brk is a no...
Item does not contain fulltextPTK6/Brk is a non-receptor tyrosine kinase overexpressed in cancer. He...
Basal-type triple-negative breast cancers (TNBC) are aggressive and difficult to treat relative to l...
<div><p>Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emer...
The non-receptor tyrosine kinase, PTK6/BRK, is highly expressed in multiple tumor types, including p...
Protein tyrosine kinase 6 (PTK6, or BRK) is aberrantly expressed in breast cancers, and emerging as ...
Deregulated signaling via receptor tyrosine kinase (RTK) pathways is prevalent in numerous types of ...
Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated wi...
Breast cancer is unanimously considered a highly heterogeneous disease due to its diverse molecular ...
Breast tumour kinase (Brk/PTK6) is overexpressed in up to 86% of breast cancers and is associated wi...
PTK6 (also known as Brk) is an intracellular tyrosine kinase whose expression is up-regulated in sev...
PTK6, also known as Brk, is highly expressed in over 80% of breast cancers. In the last decade sever...
Background: Proteins that are required for anchorage-independent survival of tumor cells represent a...
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy worldwide and is c...